7 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18546024 | METHODS AND SYSTEMS FOR GENERATING NUCLEIC ACID DIVERSITY | SU-TOBON, QIWEN NMN | 1636 | Non-Final OA | Aug 10, 2023 |
| 18245987 | HIGH THROUGHPUT METHODS AND PRODUCTS FOR SARS-COV-2 SERO-NEUTRALIZATION ASSAY | KINSEY WHITE, NICOLE ERIN | 1672 | Non-Final OA | Mar 20, 2023 |
| 18008093 | ANTI-HBV ANTIBODIES AND METHODS OF USE | ALLEN, MARIANNE P | 1647 | Non-Final OA | Dec 02, 2022 |
| 17997434 | SARS-COV-2 VIRAL PROTEINS AND USE THEREOF | CHEN, STACY BROWN | 1672 | Non-Final OA | Oct 28, 2022 |
| 17996861 | LUCIFERASE LINKED IMMUNOSORBENT ASSAY | SZPERKA, MICHAEL EDWARD | 1641 | Non-Final OA | Oct 21, 2022 |
| 17996127 | BACTERIAL STRAINS FOR USE AS PROBIOTICS, COMPOSITIONS THEREOF, DEPOSITED STRAINS AND METHOD TO IDENTIFY PROBIOTIC BACTERIAL STRAINS | ZINGARELLI, SANDRA | 1653 | Final Rejection | Oct 13, 2022 |
| 17907424 | DEFECTIVE INTERFERING VIRAL GENOMES | CHEN, STACY BROWN | 1672 | Non-Final OA | Sep 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial